Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

(3S,3aS,6R,6aR)-2-Oxohexa-hydro-furo[3,2-b]furan-3,6-diyl dibenzoate.

ABSTRACT: The title compound, C20H16O7, contains a cis-fused ?-lactone tetra-hydro-furan ring system functionalized with two benzo-yloxy groups. Both rings adopt an envelope conformation. The mol-ecule assumes an elongated shape and exibits non-crystallographic C 2 symmetry. The benzo-yloxy groups are almost planar [maximum deviations of 0.0491?(15) and 0.0336?(17)?Å for the O atoms] and their mean planes are inclined to one another by 16.51?(4)°. The crystal packing features weak C-H?O inter-actions. The aryl groups of adjacent mol-ecules are parallel shifted with face-to-face contacts and a shortest inter-molecular C?C distance of 3.482?(4)?Å.

SUBMITTER: Piccialli V

PROVIDER: S-EPMC3790370 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

(3S,3aS,6R,6aR)-2-Oxohexa-hydro-furo[3,2-b]furan-3,6-diyl dibenzoate.

Piccialli Vincenzo V Oliviero Giorgia G Zaccaria Sabrina S Centore Roberto R Tuzi Angela A

Acta crystallographica. Section E, Structure reports online 20130904 Pt 10

The title compound, C20H16O7, contains a cis-fused γ-lactone tetra-hydro-furan ring system functionalized with two benzo-yloxy groups. Both rings adopt an envelope conformation. The mol-ecule assumes an elongated shape and exibits non-crystallographic C 2 symmetry. The benzo-yloxy groups are almost planar [maximum deviations of 0.0491 (15) and 0.0336 (17) Å for the O atoms] and their mean planes are inclined to one another by 16.51 (4)°. The crystal packing features weak C-H⋯O inter-actions. The ...[more]

PMID: 24098192

Similar Datasets

(3R,3aR,6R,6aR)-Hexa-hydro-furo[3,2-b]furan-3,6-diyl dibenzoate.

Project description:The title compound, C20H18O6, prepared from d-mannitol by a two-step procedure, is a functionalized fused bis-tetra-hydro-furan. In the central fragment, consisting of two fused tetra-hydro-furan rings, one O atom and its two adjacent C atoms, a methyl-ene and a bridgehead C atom, are disordered over two sets of sites with an occupancy ratio of 0.735?(9):0.265?(9). In the major component, the ring containing the disordered O atom is a half-chair conformation with twisted methylene and benzoate-substituted C atoms, whereas the other ring has a half-chair or T-form conformation. In the minor component, the ring with the disordered O atom has an envelope conformation, with the O atom as the flap, and the other ring has a half-chair conformation, with the O atom and the other bridgehead CH atom being twisted. The two aromatic rings are inclined to one another by 20.00?(12)°. In the crystal, adjacent molecules are linked via C-H?? interactions, forming chains propagating along [010].

| S-EPMC3884481 | biostudies-literature

(3R,3aS,6R,6aR)-3-(1-Nitro-eth-yl)perhydro-furo[3,2-b]furan-3,6-diol.

Project description:The mol-ecule of the title compound, C(8)H(13)NO(6), a sucrose derivative, consists of two fused tetra-hydro-furan rings having the cis arrangement at the ring junctions, giving a V-shaped mol-ecule. An intra-molecular O-H⋯O inter-action occurs. Inter-molecular O-H⋯O hydrogen bonds help to stabilize the crystal structure.

| S-EPMC3007024 | biostudies-literature

[(2S,3aR,6aR)-5-Oxohexa-hydro-furo[3,2-b]furan-2-yl]methyl acetate.

Project description:The title compound, C9H12O5, is a bicyclic lactone, presenting a 2,6-dioxabi-cyclo-[3.3.0]octan-3-one skeleton, which was obtained through an intra-molecular lactonization. The bicyclic lactone presents a cis ring-junction and a 1,5-trans-substituted tetra-hydro-furan. Both five-membered rings are in twisted envelope conformations with one of the fused C atoms as the flap. The dihedral angle between the mean planes of the bicyclic lactone residue, defined by the di-hydro-furan-2(3H)-one and the tetra-hydro-furan rings, is 69.5 (2)°. The atoms of the ester chain are coplanar [maximum deviation = 0.013 (2) Å]. The absolute structure was not determined.

| S-EPMC3648296 | biostudies-literature

rac-(3aR,6aR)-(E)-Methyl 2-(3a-methyl-perhydro-furo[3,2-b]furan-2-yl-idene)acetate.

Project description:The constitution and relative configuration at the stereogenic centres and stereochemistry of the C-C double bond formed during Pd(II)-catalysed domino reaction was established by X-ray analysis of the title compound, C(10)H(14)O(4). The asymmetric unit contains two mol-ecules.

| S-EPMC3007948 | biostudies-literature

Diethyl 4,4'-(3,6-dioxaoctane-1,8-diyl-dioxy)dibenzoate.

Project description:The title compound, C(24)H(30)O(8), was obtained by reaction of ethyl 4-hy-droxy-benzoate with 1,2-dichloro-ethane. The mol-ecule occupies a crystallographic inversion center, with its central ethyl-ene bridge in an anti conformation. The other ethyl-ene bridge has a gauche conformation, with the corresponding O-C-C-O torsion angle being 74.2?(1)°. The benzene rings are almost coplanar with the adjacent eth-oxy-carbonyl groups, with an r.m.s. deviation of 0.078?Å.

| S-EPMC3295487 | biostudies-literature

Practical Synthesis of the Bicyclic Darunavir Side Chain: (3R,3aS,6aR)-Hexahydrofuro[2,3-b]furan-3-ol from Monopotassium Isocitrate.

Project description:A practical synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-ol-a key intermediate in the synthesis of darunavir-from monopotassium isocitrate is described. The isocitric acid salt, obtained from a high-yielding fermentation fed by sunflower oil, was converted in several steps to a tertiary amide. This amide, along with the compound's ester functionalities, was reduced with lithium aluminum hydride to give, on acidic workup, a transient aminal-triol. This was converted in situ to the title compound, the bicyclic acetal furofuranol side chain of darunavir, a protease inhibitor used in treatment of HIV/AIDS. Key to the success of this process was identifying an optimal amide that allowed for complete reaction and successful product isolation. N-Methyl aniline amide was identified as the most suitable substrate for the reduction and the subsequent cyclization to the desired product. Thus, the side chain is produced in 55% overall yield from monopotassium isocitrate.

| S-EPMC5437813 | biostudies-literature

Dimethyl 4,4'-(pyridine-2,6-diyl)dibenzoate.

Project description:The title mol-ecule, C(21)H(17)NO(4), reveals axial symmetry, with the pyridine N atom located on a crystallographic twofold axis. The mol-ecule is dish-shaped, with dihedral angles between the benzene and pyridine rings of 24.643?(1) and 24.797?(1)°, respectively. The -COO plane and the benzene ring are almost coplanar [dihedral angle = 5.286?(1)°].

| S-EPMC3009199 | biostudies-literature

(2S*,3S*,3aS*,6S*,7aR*)-3-Hy-droxy-2-[(2R*,3S*)-3-isopropyl-oxiran-2-yl]-3,6-dimethyl-3,3a,5,6,7,7a-hexa-hydro-1-benzofuran-4(2H)-one.

Project description:In the title compound, C(15)H(24)O(4), the six-membered ring shows a distorted chair conformation and the five-membered ring adopts an envelope conformation with the C atom bearing the methyl and OH groups as the flap. In the crystal, O-H?O hydrogen bonds link the mol-ecules into chains running along the a-axis direction.

| S-EPMC3470321 | biostudies-literature

1,8-Dibenzoyl-naph-tha-lene-2,7-diyl dibenzoate.

Project description:In the title compound, C(38)H(24)O(6), the phenyl rings of the benzoyl and benzo-yloxy groups make dihedral angles of 67.12?(5), 85.15?(5), 76.41?(5) and 71.47?(5)° with the naphthal-ene ring system. In the crystal, C-H?O hydrogen bonds link mol-ecules into chains parallel to the b axis. The structure also features C-H?? and ?-? stacking inter-actions, with centroid-centroid distances in the range 3.6441?(7)-3.9197?(8)?Å.

| S-EPMC3414365 | biostudies-literature

Propane-2,2-diyl di-p-phenyl-ene dibenzoate.

Project description:The V-shaped propeller-like mol-ecule of the title compound, C(29)H(24)O(4), does not exhibit crystallographic twofold symmetry as the two benzene rings are twisted asymmetrically with respect to both the central propyl plane and the benzo-yloxy groups [4.6 (2), 43.6 (2)° and 45.07 (8), 69.50 (8)°]. In the crystal structure, centrosymmetrically related mol-ecules form a dimer through C-H⋯π inter-molecular inter-actions.

| S-EPMC2915318 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data